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Synthesis of interesting β-nitrohydrazides through 
thiourea organocatalysed aza-Michael addition  
Ana Alcaine,a Eugenia Marqués-López*a and Raquel P. Herrera*a 
The synthesis of antimicrobial β-nitrohydrazides, as the goal product of our reaction, is 
reached by the first time under organocatalytic enantioselective conditions. We accomplish 
this goal by using a thiourea organocatalysed aza-Michael addition reaction of hydrazide to 
nitroalkenes, furnishing final products with good yields and good enantiomeric ratios. The 
developed methodology is one of the scarce examples of catalytic reactivity using hydrazide 
where the reaction proceeds through its N2 atom. Our developed strategy extends the 
generality of this area of research due to the difficulties of designing new nitrogen 
nucleophiles with high activity, and in addition, this is one of the scarce examples where 
nitroalkenes and chiral thioureas have been used in asymmetric organocatalytic aza-Michael 
addition reactions. 
 
Introduction 
β-Nitrohydrazides have been found to exhibit interesting 
biological properties and some patents have been focused on 
their synthesis.1 However, the only asymmetric synthesis of 
these compounds was reached by starting from the 
corresponding hydrazones and nitromethane and using a 
stoichiometric amount of a silicon Lewis acid promoter 
(Scheme 1, route a).1b In order to avoid the synthesis of the 
corresponding hydrazones and the use of a stoichiometric 
charge of the chiral promoter, we envisaged that a more 
straightforward organocatalytic aza-Michael addition reaction2,3 
of hydrazide to nitroalkenes should be an interesting and rapid 
approach for achieving the same final goal (Scheme 1, route b). 
 As β-nitrohydrazides, many other important biomolecules 
also bear stereogenic centers containing C-N bonds.4 For this 
purpose, the aza-Michael addition reaction is one of the most 
important protocols for C-N bond formation and this field has 
undergone an impressive growth in the last decade, and special 
improvements have been achieved concerning the area of 
asymmetric organocatalysis.2,5 Valuable Michael acceptor 
substrates as well as attractive nitrogen-containing nucleophiles 
have been successfully explored affording biologically and 
synthetically important building blocks such as α-6 or β-amino 
acids7 or 1,2-diamines,8 depending on the starting materials. 
 
 
Scheme 1 Synthetic approaches to chiral β‐nitrohydrazides 
 Moreover, hydrazide is a privileged structural motif present 
in many bioactive compounds with biological properties.9 Its 
use as starting material is however highly challenging, due to 
the necessary regiochemistry control on its ambident reactivity 
between the two competitive amine groups present in the 
structure. Its reactivity through the N1 has been explored in 
cross-coupling reactions or in Michael addition reactions 
(Scheme 2, routes a and b, respectively),10 whereas its reactivity 
through the N2 has been almost limited to the synthesis of 
hydrazones (Scheme 2, route c).11 Consequently, the successful 
development of new methodologies of N2 Michael addition 
reactions still represents an active synthetic challenge, and only 
Feng and co-workers have recently reported a pioneering 
example using a chiral metal Lewis acid (Scheme 2, route d).12 
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Scheme 2 Mode of reactivity exhibited by N‐acylhydrazides 
 In connection with this, we disclose here our results 
concerning a pioneering strategy for the synthesis of chiral β-
nitrohydrazides via thiourea-catalysed aza-Michael addition 
reaction of hydrazides to nitroalkenes (Scheme 3). To the best 
of our knowledge this is the first enantioselective 
organocatalysed example using hydrazide as suitable 
nucleophile in an aza-Michael addition reaction through its N2 
group. Based on our own experience activating the versatile 
nitro group13 in different organocatalytic reactions,14 we 
envisioned that catalysts acting through hydrogen bond 
interactions might be a useful tool to explore this ambiphilic 
reactivity. One of the main organocatalytic structures covering 
this large group is the thiourea/urea derivatives.14-16 In this 
context, a suitable activation of the nitro group through 
hydrogen bonds of a thiourea moiety with a reasonable 
concomitant coordination of the hydrazide group by an amine 
group present in the same catalyst, could drive the attack over 
the nitroalkene promoting this aza-Michael addition reaction in 
a bifunctional fashion (Figure 1).17,18 
 
Fig. 1 Mechanistic hypothesis for a bifunctional mode of action 
 
Results and discussion 
In order to check the viability of the aforementioned 
hypothesis, we firstly evaluated the efficiency of catalyst 3a19 
in the addition of hydrazides 1a-c to nitrostyrene 2a as model 
reaction (Scheme 3). 
 
Scheme 3 Test reaction to explore the thiourea catalysed aza‐Michael addition 
 
ARTICLE 
  | 3 
 To our delight, we obtained preliminary promising results in 
terms of reactivity and enantioselectivity using hydrazide 1b 
(75:25 e.r. and >95% yield), even if the reaction has a 
considerable background at room temperature (see supporting 
information for values). In this context, it is noteworthy that we 
perform the reaction without excess of reactants in order to 
decrease the background reaction and additionally as an 
attractive feature from an atom economy point of view.20 
Poorer results were reached with organocatalysts 3b,21 3c,22 
3d,23 and 3e24 tested under similar reaction conditions using 
hydrazide 1b (Scheme 3). Moreover, the final products were 
interestingly the result of the N2 attack by the hydrazide to the 
nitroalkene, complementing in this sense the reactivity 
observed so far in the literature with this kind of substrates for 
Michael addition reactions. 
 Encouraged by these results, and having identified 
Takemoto’s catalyst 3a as the best one, we continued the 
screening varying different parameters in the reaction model in 
order to reach the optimal reaction conditions (Table 1) (see 
supporting information for a more complete screening). 
 
Table 1 Screening of the reaction conditions.a 
 
Entry Solvent (mL) 3a 
(mol %) 
T (ºC) Time (h) Yield 
(%)b 
e.r.c 
1 Toluene (0.5) 20 r.t. 72 12 56:44 
2 Xylene (0.5) 20 r.t. 48 24 55:45 
3 CH3CN (0.5) 20 r.t. 48 >95 75:25 
4 CHCl3 (0.5) 20 r.t. 72 33 52:48 
5 CH2Cl2 (0.5) 20 r.t. 48 70 55:45 
6 THF (0.5) 20 r.t. 78 91 55:45 
7 EtOAc (0.5) 20 r.t. 20 79 65:35 
8 CH3CN (0.5) 20 5 84 87 77:23 
9 CH3CN (0.5) 10 5 40 >95 67:33 
10 CH3CN (0.25) 10 5 42 >95 80:20 
11 CH3CN (0.5) 20 27 93 91 82:18 
12 CH3CN (0.5) 10 27 72 88 82:18 
13 CH3CN (0.25) 10 27 84 >95 88:12 
14 CH3CN (0.25) 5 27 72 79 86:14 
15 CH3CN (0.25) 20 35 48 12 70:30 
16 CH3CN (0.5) 10 35 120 27 75:25 
a Experimental conditions: To a solution of thiourea 3a and nitrostyrene 2a 
(0.1 mmol) in the corresponding solvent, hydrazide 1b (0.1 mmol) was added 
at the indicated temperature. After a reasonable reaction time, product 4ba 
was isolated by flash chromatography (Hex:EtOAc, 7:3). b After isolation by 
column chromatography. c Determined by chiral HPLC analysis (Chiralpak 
IC, 80:20 Hex:EtOAc, 1 mL/min).  
 In an initial screening of solvents at room temperature 
(entries 1-7), CH3CN (entry 3) and EtOAc (entry 7) were 
identified as the solvents of choice for further variations, since 
they led to the highest values of enantiomeric ratio. Although 
we also continued with EtOAc in the ensuing screenings (see 
supporting information), we finally decided to proceed with 
CH3CN because slightly better results were rendered for similar 
conditions. It was found that lowering the temperature to 5 or –
27 °C improved enantiomeric ratios were achieved, although 
longer reaction times were required (entries 8 and 11). 
Decreasing the catalyst loading until 10 or 5 mol%, and 
increasing the concentration of the reaction mixture had a 
positive effect on the enantioselectivity without altering the 
final yield (entries 13 and 14). Unfortunately, experiments 
made lowering further the temperature to –35 °C afforded 
poorer enantioselectivities and yields (entries 15 and 16). 
Finally, the combination of 10 mol% of catalyst 3a cooling 
down the reaction mixture to –27 °C in 0.25 mL of CH3CN, led 
to a slight increase in the asymmetric induction as well as in the 
yield, providing the best reaction conditions (entry 13). 
 Subsequently, and with the best reaction conditions in hand, 
we proceeded to evaluate the scope and limitations of this aza-
Michael reaction testing different nitroalkenes bearing electron-
withdrawing and electron-donating groups, as well as aliphatic 
nitroolefins (Table 2). 
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Table 2 Scope of the thiourea catalysed aza-Michael reaction.a 
 
Entry R’ 3a (mol%) CH3CN (mL) Time (h) Product Yield (%)b e.r.c 
1d Ph, 2a 10 0.25 72 4ba 82 86:14 
2 4-F-C6H4, 2b 10 0.25 72 4bb 53 88:12 
3 4-Cl-C6H4, 2c 20 1 72 4bc 82 85:15 
4 4-Br-C6H4, 2d 20 0.5 96 4bd 86 82:18 
5 4-Br-C6H4, 2d 20 1 96 4bd 39 86:14 
6 3,4-Cl2-C6H3, 2e 20 1 72 4be 88 86:14 
7 4-MeO-C6H4, 2f 10 0.25 120 4bf 83 78:22 
8  4-MeO-C6H4, 2f 20 1 120 4bf 22 84:16 
9 2-MeO-C6H4, 2g 20 0.5 120 4bg 72 83:17 
10 2-MeO-C6H4, 2g 20 1 120 4bg 40 84:16 (>99:1)e 
11 4-Me-C6H4, 2h 20 1 96 4bh 62 84:16 
12 4-BnO-C6H4, 2i 20 0.5 120 4bi 42 85:15 
13 2-furyl, 2j 10 0.25 120 4bj 55 92:8 
14f Cy, 2k 20 0.5 72 4bk 40 64:36 
15f PhCH2CH2, 2l 20 0.5 120 4bl 47 63:37 
a Experimental conditions: To a solution of thiourea 3a and nitroalkenes 2a-l (0.1 mmol) in CH3CN, hydrazide 1b (0.1 mmol) was added at –27 ºC. 
After the corresponding reaction time, products 4ba-bl were isolated by flash chromatography (Hex:EtOAc, 7:3). b After isolation by column 
chromatography. c Determined by chiral HPLC analysis (Chiralpak IC, 80:20 Hex:EtOAc, 1 mL/min). d Reaction performed with 0.5 mmol of 
nitroalkene 2a. e Value obtained after recrystallization. f Reaction performed at –35 ºC. 
 
 As shown in Table 2, hydrazide 1b was successfully added 
to different electron-rich and electron-poor nitroalkenes 
rendering final adducts 4 with moderate to high yields and good 
enantiomeric ratios. In some cases, slightly modified reaction 
conditions were required to improve the results. For example, 
we observed higher enantioselectivities in some cases under 
more diluted conditions although with poorer yields (compare 
entries 4 and 5, 7 and 8, 9 and 10). The data do not suggest a 
clear correlation between the electronic properties of 
nitroalkenes and the enantioselectivity, although longer reaction 
times were required with electron-donor groups in the aromatic 
ring of the nitroolefins. Notably, using a heteroaromatic 
nitroalkene afforded the highest value of enantiomeric ratio 
(entry 13). In contrast, poorer results were furnished with 
aliphatic nitroolefins even to lower temperature and prolonged 
reaction times (entries 14 and 15). As a consequence, we cannot 
rule out a possible π-stacking interaction between the hydrazide 
and the aromatic ring of nitroalkenes,25 which might play an 
important role determining the preferred orientation in the 
attack. The lack of such interaction could justify the poor 
enantioselectivities observed using aliphatic substituents. We 
also scaled up the reaction to 0.5 mmol (entry 1) and it is 
worthwhile to note that similar results were provided to those 
previously furnished with 0.1 mmol (Table 1, entry 13). 
 The straightforward procedure for obtaining the final goal 
described here is simpler and “greener” than the pioneering 
protocol reported by Leighton and co-workers,1b because it is 
not necessary the use of stoichiometric amounts of the silicon 
Lewis acid promoter (1.3 equiv.). Additionally, a 
diastereomeric mixture (1:2) of the metal promoter is used in 
the patent and the absolute configuration for final products is 
not provided. Moreover, tedious conditions, anhydrous solvents 
or reagents and inert atmosphere are not required, as they are in 
the organometallic version. Furthermore, our most accessible 
catalyst 3a compared with that used in the reported patent 
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makes our procedure a more attractive alternative for this chiral 
version. 
 In order to determine the absolute configuration of our 
products, single crystal was grown from adduct 4bg, and the 
stereochemical outcome was determined to be S for final 
product (Figure 2).26 
 
Fig. 2 X‐ray crystal structure of (S)‐4bg  
We propose the following transition state to explain the role 
of the catalyst 3a based in previous mode of activation by this 
structure (Figure 3). The generally accepted mechanism in 
Michael addition reactions involves a suitable bidentate  
activation between the thiourea moiety and the nitro group, 
since the activation of nitroolefins by thiourea 3a has been 
earlier invoked in other processes.27 However, we cannot 
discard a reasonable simultaneous coordination of the 
hydrazide group by the amine group in a bifunctional fashion 
(Figure 3).18 The most acidic N1 (TS) could be involved in the 
assistance of the aza-Michael addition through a transient N-H 
bond coordination, since the deprotonation of the hydrazide is 
unlikely due to the pKa values of both species.28 According to 
this stereochemical model, the amine would drive the approach 
of the nucleophile to the Si face of the nitroalkene affording the 
S absolute configuration in all final adducts, which is consistent 
with the observed results in our products. 
 
Fig. 3 Bifunctional mode of action 
In order to support our proposed mechanism (Figure 1 and 
3), we performed different 1H-NMR experiments (Figures 4-6). 
First, catalyst 3a (0.01 mmol), and hydrazide 1b (0.01 mmol) in 
CD3CN (0.5 mL) were analysed separately in two NMR tubes 
at room temperature (Figure 4, spectra 1 and 2). Subsequently, 
a mixture of both, catalyst 3a and hydrazide 1b in the same 
concentration in CD3CN, was analysed by 1H-NMR (Figure 4, 
spectrum 3). Interestingly, the signals belonging to the N1H and 
N2H of the hydrazide disappeared in the latter spectrum, 
supporting a possible interaction between the NH’s of the 
hydrazide and the catalyst. 
 
Fig. 4 1H‐NMR experiments performed in CD3CN with thiourea 3a and hydrazide 1b (400 MHz). 
 
Spectrum 3
Spectrum 2
Spectrum 1
N2HN1H
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Additionally, in order to discard the attribution of this 
interaction to the thiourea group, we repeated the same 
experiments with thiourea 3f29 without the basic moiety (Figure 
5). In this case, in the experiment using a mixture of thiourea 3f 
and hydrazide 1b (Figure 5, spectrum 3), the signals belonging 
to the NH groups of the hydrazide remained unaltered. 
 
 
Fig. 5 1H‐NMR experiments performed in CD3CN with thiourea 3f and hydrazide 1b (400 MHz). 
 
We have also performed the same experiments in the presence 
of an external base (Figure 6). By similitude with the basic 
moiety in the thiourea 3a we chose Et3N for such a purpose. 
After to repeat the same NMR experiment for each species, we 
observed that the signals belonging to the NH groups of the 
hydrazide disappeared as a consequence of their interaction 
with the Et3N, as hypothesised. We envision that the same 
interaction should occur in our catalyst 3a. This outcome would 
also be in agreement with our proposed mechanism and will 
support the TS depicted in Figure 3. 
 
Spectrum 3
Spectrum 2
Spectrum 1
N2HN1H
N2HN1H
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Fig. 6 1H‐NMR experiments performed in CD3CN with Et3N and hydrazide 1b (400 MHz) 
 
All these facts could be also in agreement with our initial 
proposed hypothesis and the aforementioned TS concerning a 
plausible interaction between the basic moiety in the catalyst 
and the hydrazide, which would help to drive the 
enantioselective attack over the nitroalkene favouring a more 
rigid transition state. According to this theory, chiral thioureas 
in absence of a basic scaffold in their structures afforded poorer 
results in terms of both, reactivity and enantioselectivity (see 
supporting information for more experiments) (Figure 7). 
 
Fig. 7 Thioureas 3g,30 3h,31 3i14b explored  in absence of the basic moiety  in their 
structures.  (Reaction  conditions:  to  a  solution  of  thiourea  3g‐i  (20 mol%)  and 
nitrostyrene  2a  (0.1 mmol)  in  CH3CN  (0.5 mL),  hydrazide  1b  (0.1 mmol)  was 
added at room temperature) 
 
Conclusions 
In summary, we have reported an unprecedented approach of 
thiourea-catalysed aza-Michael addition reaction of hydrazides 
to nitroalkenes providing easy access to inspiring building 
blocks with biological activity.1 This work could be a pivotal 
precedent in this area of research due to the difficulties to 
design new nitrogen nucleophiles with high activity, and in 
addition, this is one of the scarce examples where nitroalkenes32 
and chiral thiourea catalysts18b,32e,d,g,33 have been used in 
asymmetric organocatalytic aza-Michael addition reactions. 
Further studies are being carried out in order to understand the 
role of the catalyst in this reaction and to clarify the function of 
the basic moiety of the catalyst and its possible coordination 
with the hydrazide.34,35 Moreover, studies applying these 
hydrazides in different Michael addition reactions are actively 
on-going in our laboratory. 
 
Experimental Section 
Representative procedure for thiourea organocatalysed aza-
Michael reaction of hydrazides to nitroalkenes 
To a solution of thiourea 3a (0.01 or 0.02 mmol) and 
nitroalkenes 2a-l (0.1 mmol) in CH3CN (0.25, 0.5 or 1 mL), 
hydrazide 1b (0.1 mmol) was added in a test tube at –27 ºC (or 
–35 ºC). After the corresponding reaction time (see Table 2), 
the residue was purified by flash chromatography (SiO2, 
hexane/EtOAc 7:3) to afford final adducts 4. Yields and 
enantiomeric ratios are reported in Table 2. 
 
Spectrum 3
Spectrum 2
Spectrum 1
N2HN1H
Et3N
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(S)-4-Nitro-N'-(2-nitro-1-phenylethyl)benzohydrazide (4ba) 
Compound 4ba was obtained as a white solid after 84 h of 
reaction at –27 ºC in >95% yield (32 mg). M.p. 134-136 ºC. 
The er of the product was determined by HPLC using a Daicel 
Chiralpak IC column (n-hexane/EtOAc = 80:20, flow rate 1 
mL/min,  = 258.8 nm): tmajor = 13.8 min; tminor = 16.8 min. 
[α]D24 = +19.3 (c = 0.20, acetone, 88:12 er). 1H NMR (400 
MHz, CD2Cl2) δ 8.24-8.27 (m, 2H), 7.78-7.81 (m, 2H), 7.60-
7.61 (m, 1H, NH), 7.40-7.46 (m, 5H), 5.41 (dd, J = 2.8, 5.7 Hz, 
1H, NH), 4.95 (ddd, J = 2.8, 4.3, 8.6 Hz, 1H), 4.84 (dd, J = 8.6, 
12.7 Hz, 1H), 4.66 (dd, J = 4.3, 12.7 Hz, 1H). 13C NMR (100 
MHz, CD2Cl2) δ 166.4 (1C), 150.3 (1C), 138.3 (1C), 136.4 
(1C), 129.6 (1C), 129.5 (2C), 128.6 (2C), 128.0 (2C), 124.3 
(2C), 79.6 (1C), 62.5 (1C). IR (KBr film) (cm–1) ν 3277, 2924, 
2854, 1621, 1593, 1561, 1537, 1524, 1456, 1426, 1376, 1345, 
1313, 1299, 719, 701, 690. HRMS (ESI+) calcd C15H14N4NaO5 
353.0856; found 353.0865 [M++Na]. 
 
(S)-N'-(1-(4-Fluorophenyl)-2-nitroethyl)-4-
nitrobenzohydrazide (4bb) 
Compound 4bb was obtained as an orange solid after 72 h of 
reaction at –27 ºC in 53% yield (18.4 mg). M.p. 165-167 ºC. 
The er of the product was determined by HPLC using a Daicel 
Chiralpak IC column (n-hexane/EtOAc = 80:20, flow rate 1 
mL/min,  = 260.0 nm): tmajor = 13.1 min; tminor = 15.9 min. 
[α]D25 = +18.0 (c = 0.94, acetone, 88:12 er). 1H NMR (400 
MHz, CD3COCD3) δ 9.68 (br s, 1H, NH), 8.28-8.32 (m, 2H), 
8.01-8.04 (m, 2H), 7.57-7.60 (m, 2H), 7.12-7.18 (m, 2H), 5.70 
(br s, 1H, NH), 5.11 (dd, J = 7.4, 12.8 Hz, 1H), 4.97-5.00 (m, 
1H), 4.86 (dd, J = 6.0, 12.8 Hz, 1H). 13C NMR (100 MHz, 
CD3COCD3) δ 167.1 (1C), 164.7 (d, J = 245.0 Hz, 1C), 151.6 
(1C), 140.5 (1C), 135.2 (m, 1C), 132.0 (d, J = 8.4 Hz, 2C), 
130.5 (2C), 125.4 (2C), 117.2 (d, J = 21.6 Hz, 2C), 80.3 (1C), 
63.1 (1C). IR (KBr film) (cm–1) ν 3261, 2924, 2854, 1631, 
1597, 1554, 1510, 1462, 1427, 1378, 1344, 1317, 1224, 1192, 
1124, 1105, 963, 887, 864, 849, 831, 818, 690. HRMS (ESI+) 
calcd C15H13FN4NaO5 371.0762; found 371.0742 [M++Na]. 
 
(S)-N'-(1-(4-Chlorophenyl)-2-nitroethyl)-4-
nitrobenzohydrazide (4bc) 
Compound 4bc was obtained as an orange solid after 72 h of 
reaction at –27 ºC in 82% yield (29,9 mg). M.p. 146-148 ºC. 
The er of the product was determined by HPLC using a Daicel 
Chiralpak IC column (n-hexane/EtOAc = 80:20, flow rate 1 
mL/min,  = 258.8 nm): tmajor = 13.5 min; tminor = 16.4 min. 
[α]D25 = +20.3 (c = 0.24, acetone, 80:20 er). 1H NMR (400 
MHz, CD2Cl2) δ 8.25-8.28 (m, 2H), 7.79-7.82 (m, 2H), 7.58-
7.59 (m, 1H, NH), 7.41 (s, 4H), 5.38 (dd, J = 2.9, 5.7 Hz, 1H, 
NH), 4.93-4.97 (m, 1H), 4.81 (dd, J = 8.4, 12.8 Hz, 1H), 4.63 
(dd, J = 4.5, 12.8 Hz, 1H). 13C NMR (100 MHz, CD2Cl2) δ 
166.5 (1C), 150.4 (1C), 138.1 (1C), 135.4 (1C), 135.0 (1C), 
129.7 (2C), 129.5 (2C), 128.6 (2C), 124.3 (2C), 79.3 (1C), 61.8 
(1C). IR (KBr film) (cm–1) ν 3274, 2924, 2854, 1733, 1674, 
1653, 1603, 1558, 1520, 1491, 1378, 1342, 1259, 1175, 1138, 
1090, 1068, 1015, 868, 850. HRMS (ESI+) calcd 
C15H13ClN4NaO5 387.0467; found 387.0488 [M++Na]. 
 
(S)-N'-(1-(4-Bromophenyl)-2-nitroethyl)-4-
nitrobenzohydrazide (4bd) 
Compound 4bd was obtained as a yellow solid after 96 h of 
reaction at –27 ºC in 86% yield (35.2 mg). M.p. 152-154 ºC. 
The er of the product was determined by HPLC using a Daicel 
Chiralpak IC column (n-hexane/EtOAc = 80:20, flow rate 1 
mL/min,  = 258.8 nm): tmajor = 13.3 min; tminor = 16.1 min. 
[α]D25 = +22.9 (c = 0.69, acetone, 82:18 er). 1H NMR (400 
MHz, CD3COCD3) δ 9.56 (br s, 1H, NH), 8.15-8.17 (m, 2H), 
7.88-7.90 (m, 2H), 7.42-7.45 (m, 2H), 7.36-7.38 (m, 2H), 5.62 
(br s, 1H, NH), 4.97 (dd, J = 7.3, 12.9 Hz, 1H), 4.83-4.87 (br m, 
1H, NH), 4.74 (dd, J = 5.9, 12.9 Hz, 1H). 13C NMR (100 MHz, 
CD3COCD3) δ 167.0 (1C), 151.6 (1C), 140.5 (1C), 138.5 (1C), 
133.5 (2C), 132.1 (2C), 130.5 (2C), 125.4 (2C), 123.9 (1C), 
80.0 (1C), 63.2 (1C). IR (KBr film) (cm–1) ν 3314, 2924, 2854, 
1646, 1597, 1543, 1522, 1460, 1376, 1350, 1306, 1073, 1011, 
876, 849, 828, 772, 724. HRMS (ESI+) calcd C15H13BrN4NaO5 
430.9962; found 430.9947 [M++Na]. 
 
(S)-N'-(1-(3,4-Dichlorophenyl)-2-nitroethyl)-4-
nitrobenzohydrazide (4be) 
Compound 4be was obtained as an orange solid after 72 h of 
reaction at –27 ºC in 88% yield (35.1 mg). M.p. 70-75 ºC. The 
er of the product was determined by HPLC using a Daicel 
Chiralpak IC column (n-hexane/EtOAc = 80:20, flow rate 1 
mL/min,  = 258.8 nm): tmajor = 11.9 min; tminor = 14.2 min. 
[α]D25 = +35.8 (c = 0.35, CHCl3, 83:17 er). 1H NMR (400 MHz, 
THF-d8) δ 9.57 (d, J = 5.5 Hz, 1H, NH), 8.25-8.28 (m, 2H), 
7.90-7.93 (m, 2H), 7.74 (d, J = 2.0 Hz, 1H), 7.53 (d, J = 8.3 Hz, 
1H), 7.43 (dd, J = 2.0, 8.3 Hz, 1H), 5.84 (dd, J = 3.7, 5.5 Hz, 
1H, NH), 4.91 (m, 2H), 4.74-4.80 (m, 1H). 13C NMR (100 
MHz, THF-d8) δ 166.4 (1C), 150.8 (1C), 139.6 (1C), 139.5 
(1C), 133.2 (1C), 133.0 (1C), 131.4 (1C), 131.1 (1C), 129.3 
(2C), 129.0 (1C), 124.2 (2C), 78.8 (1C), 61.9 (1C). IR (KBr 
film) (cm–1) ν 3286, 3108, 2959, 2927, 2857, 1659, 1601, 1554, 
1526, 1469, 1377, 1346, 1299, 1198, 1134, 1111, 1076, 1032, 
1014, 952, 868, 850, 826, 718, 683. HRMS (ESI+) calcd 
C15H13Cl2N4O5 399.0258; found 399.0234 [M++H]. 
 
(S)-N'-(1-(4-Methoxyphenyl)-2-nitroethyl)-4-
nitrobenzohydrazide (4bf) 
Compound 4bf was obtained as a yellow solid after 120 h of 
reaction at –27 ºC in 83% yield (29.9 mg). M.p. 109-111 ºC. 
The er of the product was determined by HPLC using a Daicel 
Chiralpak IC column (n-hexane/EtOAc = 80:20, flow rate 1 
mL/min,  = 260.0 nm): tmajor = 21.4 min; tminor = 27.7 min. 
[α]D25 = +21.8 (c = 0.63, acetone, 78:22 er). 1H NMR (400 
MHz, CDCl3) δ 8.24-8.27 (m, 2H), 7.78-7.81 (m, 2H), 7.73-
7.74 (m, 1H, NH), 7.31-7.34 (m, 2H), 6.90-6.93 (m, 2H), 5.31-
5.33 (m, 1H, NH), 4.89-4.93 (m, 1H), 4.79 (dd, J = 8.9, 12.4 
Hz, 1H), 4.58 (dd, J = 4.0, 12.4 Hz, 1H), 3.81 (s, 3H). 13C NMR 
(75 MHz, CDCl3) δ 166.1 (1C), 160.2 (1C), 149.9 (1C), 137.7 
(1C), 128.8 (2C), 128.2 (2C), 127.5 (1C), 124.0 (2C), 114.6 
(2C), 79.7 (1C), 61.7 (1C), 55.3 (1C). IR (KBr film) (cm–1) ν 
3287, 3110, 2924, 2854, 1663, 1603, 1547, 1515, 1463, 1377, 
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1348, 1306, 1279, 1253, 1178, 1134, 1112, 1027, 868, 851, 
834, 719, 683. HRMS (ESI+) calcd C16H16N4NaO6 383.0962; 
found 383.0942 [M++Na]. 
 
(S)-N'-(1-(2-Methoxyphenyl)-2-nitroethyl)-4-
nitrobenzohydrazide (4bg) 
Compound 4bg was obtained as a yellow solid after 120 h of 
reaction at –27 ºC in 72% yield (25.9 mg). M.p. 134-137 ºC. 
The er of the product was determined by HPLC using a Daicel 
Chiralpak IC column (n-hexane/EtOAc = 80:20, flow rate 1 
mL/min,  = 262.4 nm): tmajor = 17.2 min; tminor = 24.2 min. 
[α]D25 = +15.2 (c = 0.63, acetone, 83:17 er). 1H NMR (400 
MHz, CDCl3) δ 8.25-8.28 (m, 2H), 7.80-7.83 (m, 2H), 7.64 (br 
d, J = 4.7 Hz, 1H, NH), 7.33-7.37 (m, 2H), 6.94-7.00 (m, 2H), 
5.77 (br s, 1H, NH), 5.09-5.13 (m, 1H), 4.88 (dd, J = 8.7, 12.6 
Hz, 1H), 4.68 (dd, J = 4.0, 12.6 Hz, 1H), 3.91 (s, 3H). 13C NMR 
(75 MHz, CDCl3) δ 165.6 (1C), 157.1 (1C), 149.7 (1C), 137.8 
(1C), 130.2 (1C), 128.5 (1C), 128.2 (2C), 123.8 (2C), 123.6 
(1C), 120.9 (1C), 111.0 (1C), 77.8 (1C), 59.1 (1C), 55.5 (1C). 
IR (KBr film) (cm–1) ν 3289, 3266, 2925, 2866, 1648, 1598, 
1537, 1523, 1489, 1464, 1374, 1342, 1324, 1241, 1110, 869, 
848, 764. HRMS (ESI+) calcd C16H16N4NaO6 383.0962; found 
383.0941 [M++Na]. 
 
(S)-4-Nitro-N'-(2-nitro-1-(p-tolyl)ethyl)benzohydrazide 
(4bh) 
Compound 4bh was obtained as a yellow solid after 96 h of 
reaction at –27 ºC in 62% yield (21.3 mg). M.p. 100-102 ºC. 
The er of the product was determined by HPLC using a Daicel 
Chiralpak IC column (n-hexane/EtOAc = 80:20, flow rate 1 
mL/min,  = 260.0 nm): tmajor = 15.9 min; tminor = 19.4 min. 
[α]D24 = +24.5 (c = 0.81, acetone, 78:22 er). 1H NMR (400 
MHz, THF-d8) δ 9.53 (br d, J = 5.7 Hz, 1H, NH), 8.26 (d, J = 
8.9 Hz, 2H), 7.92 (d, J = 8.9 Hz, 2H), 7.35 (d, J = 8.0 Hz, 2H), 
7.16 (d, J = 7.9 Hz, 2H), 5.63 (dd, J = 3.6, 5.7 Hz, 1H, NH), 
4.86-4.94 (m, 2H), 4.66-4.75 (m, 1H), 2.31 (s, 3H). 13C NMR 
(100 MHz, THF-d8) δ 166.2 (1C), 150.7 (1C), 139.9 (1C), 
139.0 (1C), 135.5 (1C), 130.0 (2C), 129.3 (2C), 128.7 (2C), 
124.2 (2C), 79.7 (1C), 62.8 (1C), 21.2 (1C). IR (KBr film) (cm–
1) ν 3263, 2924, 2855, 1651, 1600, 1548, 1526, 1459, 1422, 
1378, 1346, 1307, 1224, 896, 873, 850, 822, 791, 778, 722, 
695. HRMS (ESI+) calcd C16H16N4NaO5 367.1013; found 
367.1003 [M++Na]. 
 
(S)-N'-(1-(4-(Benzyloxy)phenyl)-2-nitroethyl)-4-
nitrobenzohydrazide (4bi) 
Compound 4bi was obtained as a yellow solid after 120 h of 
reaction at –27 ºC in 42% yield (18.3 mg). M.p. 149-151 ºC. 
The er of the product was determined by HPLC using a Daicel 
Chiralpak IC column (n-hexane/EtOAc = 80:20, flow rate 1 
mL/min,  = 260.0 nm): tmajor = 19.9 min; tminor = 26.1 min. 
[α]D25 = +27.1 (c = 0.36, acetone, 85:15 er). 1H NMR (400 
MHz, CDCl3) δ 8.27-8.30 (m, 2H), 7.78-7.81 (m, 2H), 7.47 (br 
s, 1H, NH), 7.33-7.47 (m, 7H), 7.00-7.02 (m, 2H), 5.31 (br s, 
1H, NH), 5.08 (s, 2H), 4.92 (dd, J = 3.8, 8.9 Hz, 1H), 4.80 (dd, 
J = 9.0, 12.3 Hz, 1H), 4.59 (dd, J = 3.9, 12.3 Hz, 1H). 13C NMR 
(100 MHz, CD3COCD3) δ 167.0 (1C), 161.0 (1C), 151.6 (1C), 
140.7 (1C), 140.6 (1C), 139.2 (1C), 131.1 (2C), 130.5 (2C), 
130.3 (2C), 129.7 (1C), 129.5 (2C), 125.4 (2C), 116.7 (2C), 
80.5 (1C), 71.4 (1C), 63.4 (1C). IR (KBr film) (cm–1) ν 3386, 
2924, 2854, 1650, 1603, 1553, 1538, 1513, 1465, 1377, 1344, 
1327, 1231, 1178, 1002, 870, 852, 840, 747, 719, 696. HRMS 
(ESI+) calcd C22H20N4NaO6 459.1275; found 459.1254 
[M++Na]. 
 
(S)-N'-(1-(Furan-2-yl)-2-nitroethyl)-4-nitrobenzohydrazide 
(4bj) 
Compound 4bj was obtained as an orange solid after 120 h of 
reaction at –27 ºC in 55% yield (17.6 mg). M.p. 145-147 ºC. 
The er of the product was determined by HPLC using a Daicel 
Chiralpak IC column (n-hexane/EtOAc = 80:20, flow rate 1 
mL/min,  = 258.8 nm): tmajor = 17.7 min; tminor = 19.7 min. 
[α]D24 = +28.8 (c = 0.34, acetone, 92:8 er). 1H NMR (400 MHz, 
CD2Cl2) δ 8.26-8.30 (m, 2H), 7.83-7.86 (m, 2H), 7.64 (br d, J = 
5.9 Hz, 1H, NH), 7.47 (dd, J = 0.8, 1.8 Hz, 1H), 6.40-6.43 (m, 
2H), 5.44-5.46 (m, 1H, NH), 5.00-5.05 (m, 1H), 4.89 (dd, J = 
8.4, 13.3 Hz, 1H), 4.77 (dd, J = 4.9, 13.3 Hz, 1H). 13C NMR 
(75 MHz, THF-d8) δ 166.0 (1C), 151.4 (1C), 150.7 (1C), 143.8 
(1C), 139.7 (1C), 129.3 (2C), 124.2 (2C), 111.1 (1C), 109.4 
(1C), 76.7 (1C), 57.0 (1C). IR (KBr film) (cm–1) ν 3276, 2922, 
2852, 1737, 1699, 1651, 1598, 1558, 1521, 1460, 1377, 1345, 
1013. HRMS (ESI+) calcd C13H12N4NaO6 343.0649; found 
343.0649 [M++Na]. 
 
(S)-N'-(1-Cyclohexyl-2-nitroethyl)-4-nitrobenzohydrazide 
(4bk) 
Compound 4bk was obtained as an orange solid after 72 h of 
reaction at –27 ºC in 40% yield (13.4 mg). M.p. 91-93 ºC. The 
er of the product was determined by HPLC using a Daicel 
Chiralpak IC column (n-hexane/EtOAc = 80:20, flow rate 1 
mL/min, = 258.8 nm): tmajor = 12.1 min; tminor = 16.8 min. 
[α]D25 = –11.1 (c = 0.12, acetone, 64:36 er). 1H NMR (400 
MHz, CD3COCD3) δ 9.63 (br s, 1H, NH), 8.31-8.35 (m, 2H), 
8.07-8.10 (m, 2H), 5.35-5.38 (m, 1H, NH), 4.72 (dd, J = 4.2, 
13.4Hz, 1H), 4.63 (dd, J = 7.7, 13.4 Hz, 1H), 3.58-3.64 (m, 
1H), 1.89-1.93 (m, 2H), 1.65-1.80 (m, 3H), 1.15-1.34 (m, 6H). 
13C NMR (100 MHz, CD3COCD3) δ 167.0 (1C), 151.6 (1C), 
140.6 (1C), 130.5 (2C), 125.4 (2C), 78.3 (1C), 65.1 (1C), 40.8 
(1C), 30.8 (2C), 30.2 (2C), 28.0 (1C). IR (KBr film) (cm–1) ν 
3295, 2927, 2854, 1658, 1601, 1552, 1526, 1451, 1347, 1300, 
1109, 1014, 868, 849, 718. HRMS (ESI+) calcd C15H20N4NaO5 
359.1326; found 359.1313 [M++Na]. 
 
(S)-4-Nitro-N'-(1-nitro-4-phenylbutan-2-yl)benzohydrazide 
(4bl) 
Compound 4bl was obtained as an orange solid after 120 h of 
reaction at –35 ºC in 47% yield (16.8 mg). M.p. 115-117 ºC. 
The er of the product was determined by HPLC using a Daicel 
Chiralpak IC column (n-hexane/EtOAc = 80:20, flow rate 1 
mL/min,  = 258.8 nm): tmajor = 12.7 min; tminor = 14.4 min. 
[α]D25 = –10.5 (c = 0.31, acetone, 63:37 er). 1H NMR (400 
MHz, CD3COCD3) δ 9.65 (br s, 1H, NH), 8.32-8.35 (m, 2H), 
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8.11-8.14 (m, 2H), 7.27 (br d, J = 4.4 Hz, 4H), 7.16-7.21 (m, 
1H), 5.50-5.53 (br m, 1H, NH), 4.74 (dd, J = 7.2, 13.4 Hz, 1H), 
4.68 (dd, J = 5.0, 13.4 Hz, 1H), 3.74-3.81 (m, 1H), 2.85-2.96 
(m, 2H), 1.96-2.09 (m, 1H), 1.83-1.92 (m, 1H). 13C NMR (75 
MHz, CDCl3) δ 166.3 (1C), 150.0 (1C), 140.4 (1C), 137.5 (1C), 
128.7 (2C), 128.3 (2C), 128.2 (2C), 126.5 (1C), 124.0 (2C), 
78.2 (1C), 58.5 (1C), 32.2 (1C), 31.9 (1C). IR (KBr film) (cm–
1) ν 3362, 3292, 3103, 3025, 3002, 2926, 2853, 1659, 1597, 
1548, 1519, 1495, 1470, 1454, 1414, 1383, 1352, 1316, 1297, 
1112, 1083, 1011, 910, 867, 847, 792, 754, 713, 696. HRMS 
(ESI+) calcd C17H18N4NaO5 381.1169; found 381.1163 
[M++Na]. 
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